Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Beam Therapeutics Inc. (BEAM)  
$25.70 0.00 (0.00%) as of 4:30 Mon 4/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 81,510,000
Market Cap: 2.09(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $17.69 - $45.07
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Beam Therapeutics is a biotechnology company. Co. has identified four development candidates to date: three from its ex vivo platform, with two candidates targeting hemoglobinopathies and one candidate targeting T-cell leukemia, and one from its in vivo platform targeting glycogen storage disease. BEAM-102 directly corrects the causative mutation in sickle cell disease by recreating a naturally-occurring normal human hemoglobin variant, HbG-Makassar. BEAM-201 is an anti-CD7, multiplex edited, allogeneic chimeric antigen receptor T cell development candidate for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 1,076,735 1,092,090 1,249,399 1,667,862
Total Sell Value $32,842,473 $33,262,334 $38,301,409 $57,111,391
Total People Sold 6 6 6 6
Total Sell Transactions 10 13 17 42
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 168
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Simon Amy Chief Medical Officer   •       –      –    2024-04-02 4 AS $30.54 $504,851 D/D (16,530) 70,060 -15%     
   Simon Amy Chief Medical Officer   •       –      –    2024-04-01 4 AS $32.13 $229,954 D/D (7,157) 86,590 -21%     
   Bellon Christine Chief Legal Officer   •       –      –    2024-04-01 4 AS $32.12 $109,240 D/D (3,401) 104,594 -21%     
   Burrell Terry-Ann Chief Financial Officer   •       –      –    2024-04-01 4 AS $32.12 $174,926 D/D (5,446) 70,137 -21%     
   Evans John M. CEO   •       •      –    2024-04-01 4 AS $32.13 $581,617 D/D (18,102) 1,058,343 -21%     
   Ciaramella Giuseppe President   •       –      –    2024-04-01 4 AS $32.12 $145,632 D/D (4,534) 169,616 -21%     
   Simon Amy Chief Medical Officer   •       –      –    2024-03-31 4 A $0.00 $0 D/D 27,500 93,747     -
   Bellon Christine Chief Legal Officer   •       –      –    2024-03-31 4 A $0.00 $0 D/D 27,500 107,995     -
   Ciaramella Giuseppe President   •       –      –    2024-03-31 4 A $0.00 $0 D/D 35,000 174,150     -
   Burrell Terry-Ann Chief Financial Officer   •       –      –    2024-03-31 4 A $0.00 $0 D/D 27,500 75,583     -
   Evans John M. CEO   •       •      –    2024-03-31 4 A $0.00 $0 D/D 77,500 1,076,445     -
   Evans John M. CEO   •       •      –    2024-03-28 4 AS $33.86 $2,031,402 D/D (60,000) 998,262 -22%     
   Fmr Corp See Remark 1   –       –      –    2024-02-14 4 S $30.51 $27,496,912 I/I (900,000) 1,235,511 18%     
   Fmr Corp See Remark 1   –       –      –    2024-02-13 4 S $30.28 $48,139 I/I (1,565) 2,771,913 14%     
   Evans John M. CEO   •       •      –    2024-01-31 4 AS $25.33 $1,519,800 D/D (60,000) 1,058,262 6%     
   Bellon Christine Chief Legal Officer   •       –      –    2024-01-03 4 AS $26.42 $50,383 D/D (1,907) 80,495 0%     
   Fmr Corp See Remark 1   –       –       •   2023-12-22 4 D $0.00 $0 I/I (29,549) 2,773,478     -
   Bellon Christine Chief Legal Officer   •       –      –    2023-11-20 4 AS $30.00 $305,000 D/D (10,000) 82,402 -1%     
   Bellon Christine Chief Legal Officer   •       –      –    2023-11-20 4 OE $7.22 $72,200 D/D 10,000 92,402     -
   Simon Amy Chief Medical Officer   •       –      –    2023-10-30 4 AS $18.70 $64,478 D/D (3,448) 65,469 91%     
   Ciaramella Giuseppe President and CSO   •       –      –    2023-10-20 4 OE $0.67 $60,903 D/D 90,900 139,150     -
   Bellon Christine Chief Legal Officer   •       –      –    2023-10-02 4 AS $22.85 $8,866 D/D (388) 82,402 35%     
   Ciaramella Giuseppe President and CSO   •       –      –    2023-07-24 4 AS $32.01 $38,604 D/D (1,206) 48,250 -9%     
   Ciaramella Giuseppe President and CSO   •       –      –    2023-07-24 4 OE $7.22 $8,707 D/D 1,206 49,456     -
   Ciaramella Giuseppe President and CSO   •       –      –    2023-07-21 4 AS $32.06 $4,979,687 D/D (155,324) 48,250 -7%     
  168 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us